Nutrition, Intestinal Permeability, and Blood Ethanol Levels Are Altered in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Background A role of an altered dietary pattern (e.g., a diet rich in sugar) but also alterations at the level of the intestinal barrier have repeatedly been discussed to be involved in the development and progression of nonalcoholic fatty liver disease (NAFLD).Aims To determine if the nutritional intake, intestinal flora, and permeability and the development of NAFLD are related in humans.Methods Ten controls and 20 patients with NAFLD ranging from simple steatosis to steatohepatitis were included in the study. Bacterial overgrowth, orocecal transit time, and intestinal permeability were assessed. Alcohol, endotoxin, and plasminogen activator inhibitor (PAI-) 1 concentration were determined in plasma. Nutritional intake was assessed using a dietary history.Results Despite no differences in the prevalence of bacterial overgrowth and in the orocecal transit time, intestinal permeability, alcohol, and endotoxin levels in plasma were significantly higher in patients with NAFLD than in controls. Similar results were also found for PAI-1 plasma concentrations. Patients with NAFLD had a significantly higher intake of protein, total carbohydrates, and mono- as well as disaccharides than controls. PAI-1, endotoxin, and ALT plasma levels were positively related to total protein and carbohydrate intake.Conclusions Taken together, our results indicate that intestinal permeability, endogenous alcohol synthesis, and nutritional intake are markedly altered in patients with NAFLD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with NAFLD ranging from simple NAFLD to NASH showed higher intestinal permeability as assessed by a lactulose/mannitol test, alcohol, and endotoxin levels in plasma in comparison with controls [295].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [295]
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · cited 1×
“For ethical reasons, it was not possible to obtain biopsy samples from all subjects; however, liver biopsies of three NAFLD patients were taken and histological assessment was performed by an experienced pathologist using the NAS-score [20].”
Method(2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,178
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890 · cited 1×
“, steatohepatitis and cirrhosis) [2].”
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., Mascianà, R., Forgione, A., Gabrieli, M. L., Perotti, G., et al. (2009) · Hepatology · doi:10.1002/hep.22848 · Cited by 1,434 · cited 11×
“As described before by Parlesak et al. and Miele et al., a rise in breath hydrogen [10 ppm within the first 10–20 min after glucose ingestion was considered as an indication of small intestinal bacterial overgrowth (SIBO) [30, 31].”
BackgroundResultInfluentialFructose consumption as a risk factor for non-alcoholic fatty liver disease
Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 863
Wigg, A. J., Roberts-Thomson, I. C., Dymock, R. B., McCarthy, P. J., Grose, R. H., & Cummins, A. G. (2001) · Gut · doi:10.1136/gut.48.2.206 · Cited by 840
Abdelmalek, M. F., Suzuki, A., Guy, C., Unalp-Arida, A., Colvin, R., Johnson, R. J., & Diehl, A. M. (2010) · Hepatology · doi:10.1002/hep.23535 · Cited by 770
Zelber-Sagi, S., Nitzan-Kaluski, D., Goldsmith, R., Webb, M., Blendis, L., Halpern, Z., & Oren, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.020 · Cited by 551
Bode, C., Kugler, V., & Bode, J. C. (1987) · Journal of Hepatology · doi:10.1016/s0168-8278(87)80003-x · Cited by 529
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: Role of endotoxin
Bergheim, I., Weber, S., Vos, M., Krämer, S., Volynets, V., Kaserouni, S., McClain, C. J., & Bischoff, S. C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.035 · Cited by 522
Self-citationComparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease
Joseph, A. E. A., Saverymuttu, S. H., Al-Sam, S., Cook, M. G., & Maxwell, J. D. (1991) · Clinical Radiology · doi:10.1016/s0009-9260(05)80350-2 · Cited by 515
Manufacturing, composition, and applications of fructose
Hanover, L., & White, J. (1993) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/58.5.724s · Cited by 440
Thuy, S., Ladurner, R., Volynets, V., Wagner, S., Strahl, S., Königsrainer, A., Maier, K.-P., Bischoff, S. C., & Bergheim, I. (2008) · The Journal of Nutrition · doi:10.1093/jn/138.8.1452 · Cited by 412
Self-citationElevated endotoxin levels in non-alcoholic fatty liver disease
Harte, A. L., da Silva, N. F., Creely, S. J., McGee, K. C., Billyard, T., Youssef-Elabd, E. M., Tripathi, G., Ashour, E., Abdalla, M. S., Sharada, H. M., et al. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-15 · Cited by 390
Cope, K., Risby, T., & Diehl, A. M. (2000) · Gastroenterology · doi:10.1053/gast.2000.19267 · Cited by 357
Soft Drink Consumption Linked with Fatty Liver in the Absence of Traditional Risk Factors
Assy, N., Nasser, G., Kamayse, I., Nseir, W., Beniashvili, Z., Djibre, A., & Grosovski, M. (2008) · Canadian Journal of Gastroenterology · doi:10.1155/2008/810961 · Cited by 331
Purohit, V., Bode, J. C., Bode, C., Brenner, D. A., Choudhry, M. A., Hamilton, F., Kang, Y. J., Keshavarzian, A., Rao, R., Sartor, R. B., et al. (2008) · Alcohol · doi:10.1016/j.alcohol.2008.03.131 · Cited by 325 · cited 1×
“Results of several animal and human studies suggest that similar to alcoholic liver disease, bacterial overgrowth and an impaired function of the intestinal barrier may be involved in the pathogenesis of NAFLD [3, 4].”
BackgroundAn enzymatic method for the microdetermination of ethanol
Bonnichsen, R. K., & Theorell, H. (1951) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365515109060572 · Cited by 281
Guerra Ruiz, A., Casafont, F., Crespo, J., Cayón, A., Mayorga, M., Estebanez, A., Fernadez-Escalante, J. C., & Pons-Romero, F. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9243-7 · Cited by 269
Dietary habits and nutrient intake in non-alcoholic steatohepatitis
Toshimitsu, K., Matsuura, B., Ohkubo, I., Niiya, T., Furukawa, S., Hiasa, Y., Kawamura, M., Ebihara, K., & Onji, M. (2007) · Nutrition · doi:10.1016/j.nut.2006.09.004 · Cited by 264
Farhadi, A., Gundlapalli, S., Shaikh, M., Frantzides, C., Harrell, L., Kwasny, M. M., & Keshavarzian, A. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01723.x · Cited by 224
Dietary Composition and Nonalcoholic Fatty Liver Disease
Solga, S., Alkhuraishe, A. R., Clark, J. M., Torbenson, M., Greenwald, A., Diehl, A. M., & Magnuson, T. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000043367.69470.b7 · Cited by 213
Nair, S. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02265-1 · Cited by 212
The Lactulose Hydrogen Breath Test as a Diagnostic Test for Small-Bowel Bacterial Overgrowth
Rhodes, J. M., Middleton, P., & Jewell, D. P. (1979) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365527909179892 · Cited by 211
Taylor, K. J., Riely, C. A., Hammers, L., Flax, S., Weltin, G., Garcia-Tsao, G., Conn, H. O., Kuc, R., & Barwick, K. W. (1986) · Radiology · doi:10.1148/radiology.160.1.3520657 · Cited by 193
Kang, H., Greenson, J. K., Omo, J. T., Chao, C., Peterman, D., Anderson, L., Foess-Wood, L., Sherbondy, M. A., & Conjeevaram, H. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00719.x · Cited by 180
Plasma PAI-1 Levels Are More Strongly Related to Liver Steatosis Than to Adipose Tissue Accumulation
Alessi, M.-C., Bastelica, D., Mavri, A., Morange, P., Berthet, B., Grino, M., & Juhan-Vague, I. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000077401.36885.bb · Cited by 178
Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats
Baraona, E., Julkunen, R., Tannenbaum, L., & Lieber, C. S. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90081-8 · Cited by 169
Ultrasound in the detection of chronic liver disease (the “bright liver”)
Joseph, A. E. A., Dewbury, K. C., & McGuire, P. G. (1979) · The British Journal of Radiology · doi:10.1259/0007-1285-52-615-184 · Cited by 166
La Brooy, S. J., Male, P. J., Beavis, A. K., & Misiewicz, J. J. (1983) · Gut · doi:10.1136/gut.24.10.893 · Cited by 151
Ibrahim, W. H., Lee, U., Yeh, C., Szabö, J., Bruckner, G. G., & Chow, C. K. (1997) · Journal of Nutrition · doi:10.1093/jn/127.7.1401 · Cited by 148
Intestinal permeability is increased in patients with advanced cirrhosis.
Pascual, S., Such, J. M., Esteban, A., Zapater, P., Casellas, J. A., Aparicio, J. R., Girona, E., Gutiérrez, A., Carnices, F., Palazón, J. M., et al. (2003) · PubMed · Cited by 137
Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice
Yang, L., Bataller, R. A., Dulyx, J., Coffman, T. M., Ginès, P., Rippe, R. A., & Brenner, D. A. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.034 · Cited by 114
Parlesak, A., Klein, B., Schecher, K., Bode, J. C., & Bode, C. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1365-2389.2003.51259.x · Cited by 111
Endogenous ethanol production and hepatic disease following jejunoileal bypass for morbid obesity
Mezey, E., Imbembo, A., Potter, J., Rent, K., Lombardo, R., & Holt, P. R. (1975) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/28.11.1277 · Cited by 102
Cariello, R., Federico, A., Sapone, A., Tuccillo, C., Scialdone, V. R., Tiso, A., Miranda, A., Portincasa, P., Carbonara, V., Palasciano, G., et al. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.05.001 · Cited by 95
Fleming, S. C., Kapembwa, M. S., Laker, M. F., Levin, G. E., & Griffin, G. E. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.5.797 · Cited by 93
Lycopene, β-carotene, and colorectal adenomas
Erhardt, J. G., Meisner, C., Bode, J. C., & Bode, C. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.6.1219 · Cited by 84
Restriction of dietary calories, fat and iron improves non‐alcoholic fatty liver disease
Yamamoto, M., Iwasa, M., Iwata, K., Kaito, M., Sugimoto, R., Urawa, N., Mifuji, R., Konishi, M., Kobayashi, Y., & Adachi, Y. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04548.x · Cited by 68
Generoso, M., ROSA, M. D., Rosa, R. D., de Magistris, L., Secondulfo, M., Fiandra, R., Carratu, R., & Cartenì, M. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00766-3 · Cited by 61
Lê, K.-A., & Bortolotti, M. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328302f3ec · Cited by 60 · cited 1×
“Results of several studies suggest that the composition of the diet may be an important factor in the onset but also progression of NAFLD in humans [15, 35, 48].”
BackgroundCharacterization of Endogenous Ethanol in the Mammal
McManus, I. R., Contag, A. O., & Olson, R. E. (1960) · Science · doi:10.1126/science.131.3393.102 · Cited by 54
Increased Orocecal Transit Time in Patients with Nonalcoholic Fatty Liver Disease
Soza, A., Riquelme, A. J., Gonzalez, R. G., Alvarez, M. G., Pérez‐Ayuso, R. M., Glasinovic, J. C., & Arrese, M. A. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2720-8 · Cited by 52
Hunnisett, A., Howard, J., & Davies, S. (1990) · Journal of Nutritional Medicine · doi:10.3109/13590849009003132 · Cited by 49
Gill, H. K., & Wu, G. Y. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i3.345 · Cited by 43
Validation and comparison of two computerized methodsof obtaining a diet history
Landig, J., Erhardt, J. G., Bode, J. C., & Bode, C. (1998) · Clinical Nutrition · doi:10.1016/s0261-5614(98)80004-6 · Cited by 32
Investigation of intestine function during acute viral hepatitis using combined sugar oral loads.
Parrilli, G., Cuomo, R., Nardone, G., Maio, G. D., Izzo, C. M., & Budillon, G. (1987) · Gut · doi:10.1136/gut.28.11.1439 · Cited by 26
Liu, H., Zhang, S., Yu, A., Qu, L., Zhao, Y., Huang, H., & Li, J. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.01.107 · Cited by 24
Endogenous Ethanol Production in a Child with Short Gut Syndrome
Logan, B. K., & Jones, A. W. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200303000-00026 · Cited by 10
Cited by
Zhu, L., Baker, S. S., Gill, C., Liu, W., Alkhouri, R., Baker, R. D., & Gill, S. R. (2013) · Hepatology · doi:10.1002/hep.26093 · Cited by 1,708
“Recently, elevated blood ethanol concentration was observed in NAFLD patients.(34) The observation of Volynets et al.”
BackgroundThe gut-liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
The intestinal microbiota fuelling metabolic inflammation
Tilg, H., Zmora, N., Adolph, T. E., & Elinav, E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0198-4 · Cited by 1,089
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Aron-Wisnewsky, J., Vigliotti, C., Witjes, J., Le, P., Holleboom, A. G., Verheij, J., Nieuwdorp, M., & Clément, K. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0269-9 · Cited by 1,063
Metadata
- Authors
- Volynets, V., Küper, M. A., Strahl, S., Maier, I. B., Spruss, A., Wagnerberger, S., Königsrainer, A., Bischoff, S. C., & Bergheim, I.
- Affiliations
- University of Hohenheim (DE)
- Universitätsklinikum Tübingen (DE)
- Klinikum Esslingen (DE)
- Corresponding author
- Bergheim, Ina
- Venue
- Digestive Diseases and Sciences
- Published
- 2012-03-17
- Volume
- 57
- Issue
- 7
- Pages
- 1932-1941
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W1997273123
- Cited by
- 268
- References
- 49
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 20 · 2023: 15 · 2022: 16 · 2021: 29 · 2020: 31 · 2019: 30 · 2018: 21 · 2017: 16 · 2016: 20 · 2015: 20 · 2014: 14 · 2013: 13 · 2012: 3
- FWCI
- 11.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- non-alcoholic fatty liver disease, intestinal permeability, blood ethanol levels, endotoxin, plasminogen activator inhibitor-1, bacterial overgrowth, orocecal transit time, nutritional intake, dietary sugar, intestinal barrier, steatohepatitis
- MeSH terms
- Adult, Ethanol, Dietary Carbohydrates, Dietary Proteins, Endotoxins, Fatty Liver, Female, Humans, Intestines, Male, Nutritional Status, Permeability, Case-Control Studies, Plasminogen Activator Inhibitor 1, Disease Progression, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.